WAEPS - Monthly Scientific Meetings  

Presented jointly with the University of Washington Department of Ophthalmology

Join your colleagues for a monthly learning session presented by top experts in a variety of ophthalmology sub-specialties.

The Monthly Scientific Meeting series is available to members throughout the state via webinar. Be sure to register online on the WAEPS website and you will automatically receive an email with login instructions the day before the lecture. Please check your junk box for the email confirmation as many webinar links tend to be considered spam.

In-Person program (when in Phase 3) is held at the 7th Floor Conference Room in the 9th and Jefferson Building (908 Jefferson St.) in Seattle from 6:30 p.m. to 8:30 p.m. Or contact the WAEPS office: waeps@waeps.org

  • Schedule: Check in and light refreshments: 6:00 p.m. |  Presentations at 6:30 and 7:30 p.m.

WAEPS members may self-register online for each month’s program using the link at the bottom of this page.  Your automatic confirmation email will contain the webinar login information for that month’s session.  If you need assistance with registration or do not receive your confirmation, please contact the WAEPS office no later than 3 p.m. on the day of the session you plan to participate in. 

View Monthly Meeting Archive

(Requires Member Login)

2020 - 2021 Monthly Scientific Meeting Series: 

October 21, 2020 
Stacy L. Pineles, MD. 

Residency Program Director  
University of California 
Los Angeles, CA 

 

Disclosures: Dr. Pineles has no ACCME defined commercial interests. Her presentation will be evidence based and free of bias. 
 
Lecture 1:  Pediatric Neuro-Ophthalmology: Why kids are not just tiny adults;   

Learning objectives: 

 After participating in this activity, attendees should be able to: 

  1. Describe the diagnosis and treatment of pseudotumor cerebri in children
  2. Discuss differences in demographics and medical comorbidities between adults and children with pseudotumor cerebri 
  3. Explain the diagnosis and treatment of myasthenia gravis in children. 

 

Lecture 2:  Pediatric Neuro-Ophthalmology: Why kids are not just tiny adults;  

Learning objectives: 

 After participating in this activity, attendees should be able to: 

  1. Describe the diagnosis and treatment of optic neuritis in children
  2. Discuss differences in demographics and medical comorbidities between adults and children with optic neuritis
  3. Understand the visual prognosis for children with optic neuritis

 Register Online
November 18, 2020
Nadia K. Waheed, MD, MPH
Retina Specialist 
Associate Professor 
Tufts University School of Medicine 

Disclosures: Dr. Waheed has no ACCME defined commercial interests. Her presentation will be evidence based and free of bias. 

Lecture 1: Clinical utility of OCTA

Learning objectives: 

After participating in this activity, attendees should be able to: 

1.  Understand what clinical situations OCTA is useful in
2.  Understand the limitations of OCTA technology 
3.  Be able to appropriately deploy OCTA in a clinical practice.
 

Lecture 2: Interpretation of OCT/OCTA and interesting cases

Learning objectives: 

 After participating in this activity, attendees should be able to: 

1. Identify choroidal neovascularization on OCTA
2. Identify artifacts on OCTA
3. Be able to correlate OCT and OCTA findings to make diagnosis.
Register Online

December 16, 2020 
Steven S. Saraf, MD 
Assistant Professor 
Dept. of Ophthalmology  
University of Washington 
Seattle, WA 

Disclosures: Dr. Saraf has no ACCME defined commercial interests. His presentation will be evidence based and free of bias.  

Lecture 1. The Choroid: The Final Frontier 

Learning objectives: 

 After participating in this activity, attendees should be able to: 

1.Identify conditions in retina and uveitis where extended evaluation of the choroid may be of clinical utility. 
2. Interpret the testing modalities used to assess the choroid, including enhanced depth imaging optical coherence tomography (OCT), indocyanine angiography, OCT angiography, and choroidal vascularity index (CVI). 
3. Describe the features of pachycormid spectrum disorders. 
4. Utilize testing modalities to assess choroidal neovascularization and distinguish subclinical choroidal neovascularization from clinically active choroidal neovascularization.   

 

Lecture 2. Ocular Complications of Novel Cancer Therapies
 Learning objectives: 

After participating in this activity, attendees should be able to: 

1. Understand the mechanism of action of novel cancer therapies (immunotherapy, targeted therapy) and the impact of these agents on systemic health and patient survival. 
2.Recall characteristic manifestations of novel cancer therapies when adversely affecting the eye. 
3. Identify strategies to manage ocular side effects while maximizing systemic benefit for patients on these agents. 
Register Online

 

 January 20, 2021   
Mark Rosenblatt, MD, PhD, MBA, MHA 
Executive Dean of the College of Medicine 
Department of Ophthalmology 
University of Illinois 

 

Disclosures: Dr. Rosenblatt has disclosed the following relationships with ACCME defined commercial interests:  

  • Consulting, speaking & teaching with Lauren Therapeutics and Nektar Therapeutics 
  • Grant / Research support: NIH, RPB, Falk Foundation 

 
 Lecture 1: The Future of Eye Banking: Quo Vadis? 

Learning objectives: 

 After participating in this activity, attendees should be able to: 

1. Identify new tissue engineering therapeutics to treat corneal disease 
2.Learn how surgeons obtain their cadaveric corneal tissue 

 
Lecture 2:  Corneal nerve repair: Structure and Function 

Learning objectives:

 After participating in this activity, attendees should be able to: 

1. Assessment and care of dry eye patients 
2. Identify disorders of the corneal nerves that have many consequences including dry eye disease. 
3. Understand that corneal nerves are essential to the health of the ocular surface 

Register Online

February 17, 2021 
Speaker:  Steven J. Gedde, MD  

Vice Chair of Education 
Department of Ophthalmology 
University of Miami School of Medicine 
Miami, Florida 
 
Disclosures: Dr. Gedde has no ACCME defined commercial interests. His presentation will be evidence based and free of bias. 

 
Lecture 1:  The (R)evolution of Glaucoma surgery 

Learning objectives: 

 After participating in this activity, attendees should be able to: 

1.Discuss the indications of incisional glaucoma surgery 
2.Identify traditional glaucoma procedures used in the surgical management of glaucoma 
3.Discribe newer procedures classified in minimal invasive glaucoma surgery (MIGS). 

 
Lecture 2: Lessons learned from glaucoma clinical trails 

Learning objectives: 

 After participating in this activity, attendees should be able to: 

1.Discribe the study designs of several multicenter randomized clinical trails in glaucoma  
2.Discuss the major findings of recent clinical trials on glaucoma 
3. Apply results of glaucoma clinical trials to patient care.

 Register Online

March 17, 2021 
Speaker:  Jonathan D. Trobe, MD 

Professor of Neurology 
University of Michigan Medical Center  
Ann Arbor, MI 

 Disclosures: Dr. Trobe has no ACCME defined commercial interests. His presentation will be evidence based and free of bias. 

 Lecture 1: Tips and Traps in the Evaluation of Diplopia (part 1) 

Learning objectives: 

 After participating in this activity, attendees should be able to: 

1. Know the common mistakes in evaluating diplopia 
2.  Know how to deploy the diagnostic tools in evaluating diplopia 

 
Lecture 2: Tips and Traps in the Evaluation of Diplopia (part 2) 

Learning objectives: 

 After participating in this activity, attendees should be able to: 

  1. Know the medical consequences of failing to make an early diagnosis 
 Register Online 

 April 21, 2021 
Speaker: M. Reza Vagefi, MD 

Professor of Ophthalmology  
University of California  
San Francisco, CA 

 

Disclosures: Dr. Vagefi has disclosed the following relationships with ACCME defined commercial interests:  

  • Grant / Research support: That Man May See, Sarah and Evan Williams Foundation 

 

Lecture 1: Freeze the Squeeze: Update on Blepharospasm 

Learning objectives: 

 After participating in this activity, attendees should be able to: 

1.Understand the clinical presentation of blepharospasm 
2.Apply concepts in disease mechanism of blepharospasm 
3 Describe current treatment options for blepharospasm. 

 
Lecture 2: No Pain, All Gain: Caring for the Blind Painful Eye 

Learning objectives: 

 After participating in this activity, attendees should be able to: 

1. Discuss the mechanisms of pain in a blind eye 
2. Understand an escalating treatment paradigm for a blind painful eye 
3. Assess the efficacy of different treatment modalities for a blind painful eye

Register Online

May 19, 2021 
Speaker: Eric A. Pierce, MD 

Associate Professor 
Harvard Medical School 
Boston, MA 

 

Disclosures: Dr. Pierce has disclosed the following relationships with ACCME defined commercial interests:  

  • Consulting, speaking & teaching: Sana Biotechnology  
  • Grant / Research support: Editas 
  • Advisory Committee or Review PanalsOpsis Therapeutics  

 Lecture 1: Genetics of Inherited Retinal Degenerations 

Learning objectives: 

 After participating in this activity, attendees should be able to: 

1. Have a better understanding of the genetic causality of inherited retinal degenerations. 

 

 Lecture 2: Clinical Translation of Genetic Therapies for Inherited Retinal Degenerations 

Learning objectives: 

 After participating in this activity, attendees should be able to: 

1.Be educated and informed regarding clinical use of genetic therapies for inherited retinal degenerations 

Register Online

 

_______________________________

 

Credit for the series is an exclusive WAEPS member benefit and free of charge. Members in good standing of neighboring states' ophthalmology societies may also be eligible.  Check with the WAEPS office for details.

CME Info: Note that to earn CME credit you must track your attendance and submit a credit claim form at the end of the series and you must sign in to each session you attend. More details will be made available when you register. Click here to download the form for the 2020 - 2021 series. 

Attention California Ophthalmologists: If you are registering from California, please contact your Society Executive VP Craig Kliger ([email protected])  to register. Do not register via the WAEPS online tool.

If you participated in a previous year's series and have a question about your CME credit, please contact Kimberly Conn, WAEPS Executive Director: [email protected] or phone: 206-956-3652.


 Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Washington School of Medicine and Washington Academy of Eye Physicians and Surgeons. The University of Washington School of Medicine is accredited by the ACCME to provide continuing medical education for physicians

The University of Washington School of Medicine designates this live activity for a maximum of 16.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  (Each session is 2.0 credits)

Planning Committee Disclosures:
Committee member Dr. Yewlin Chee, MD, has no relevant commercial interests to disclose.
Committee member Dr. Russell Van Gelder has no relevant commercial interests to disclose.

To view an archive of past Monthly WAEPS Scientific Meetings, please click here.  Please note, you must be logged in to access the archive page.